Showing results (21-30 of 68) with videos related to
Sort By:
Pageof 7
Scientific Reports|December 4, 2019
Concurrent administration of IFNα14 and cART in TKO-BLT mice enhances suppression of HIV-1 viremia but does not eliminate the latent reservoirKathrin Sutter, Kerry J Lavender, Ronald J Messer, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 21, 2025
Identification of nsp16 inhibitors of SARS -CoV-2, SARS -CoV-1 and MERS-CoV from FDA-approved drugs using in silico and in vitro methodsEjlal A Omer, Sara Abdelfatah, Nasim Shahhamzehei, et al.Journal of Medical Virology|February 15, 2020
Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoVJia Liu, Xin Zheng, Qiaoxia Tong, et al.Plos Pathogens|January 25, 2024
Influenza virus infection enhances tumour-specific CD8+ T-cell immunity, facilitating tumour controlPhiline Steinbach, Eva Pastille, Lara Kaumanns, et al.Journal of Cell Science|June 10, 2024
Reduced vacuolar ATPase protects mice from Friend virus infection - an unintended but instructive effect in Hif-2afl miceTimm Schreiber, Nora Koll, Claudia Padberg, et al.Scientific Reports|August 12, 2017
Fas Ligand-mediated cytotoxicity of CD4+ T cells during chronic retrovirus infectionAnna Malyshkina, Elisabeth Littwitz-Salomon, Kathrin Sutter, et al.Mbio|October 24, 2023
Targeted mutations in IFNα2 improve its antiviral activity against various virusesZehra Karakoese, Vu-Thuy Khanh Le-Trilling, Jonas Schuhenn, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 14, 2025
Diketopiperazine/piperidine alkaloid as a potential broad-spectrum coronaviral entry inhibitor identified by supercomputer-based virtual screening from a large natural product-based libraryNasim Shahhamzehei, Sara Abdelfatah, Ejlal A Omer, et al.Frontiers in Immunology|October 15, 2019
Diverse Immunomodulatory Effects of Individual IFNα Subtypes on Virus-Specific CD8+ T Cell ResponsesJulia Dickow, Sandra Francois, Rouven-Luca Kaiserling, et al.Frontiers in Immunology|October 31, 2022
IFNα subtype-specific susceptibility of HBV in the course of chronic infectionXiaohong Xie, Zehra Karakoese, Dilhumare Ablikim, et al.Pageof 7